Im an old man, a number of news outlets reported him as saying on his podcast
Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review
Patients treated with Tirzepatide experienced an average HbA1c reduction of up to 2.4 percentage points, which is a significant improvement over many existing diabetes medications
Because AOD9604 is not FDAapproved and cannot be compounded under current guidance, it is offered only under a strict informed consent framework with full transparency about its investigational status, potential risks, and mixed efficacy data
May your reconstitutions stay precise, your titrations stay gradual, and your protocols stay consistent.
Regulatory agencies must adapt to ensure safe distribution and use of substances like BPC 157, protecting public health and responding to consumer demand